Alkyl amines chemicals Limited has completed the allotment of 75 equity shares to eligible employees under its Employee Stock Option Plan 2018 (ESOP-2018) on December 19, 2025. The allotment was approved through a circular resolution passed by the Nomination and Remuneration Committee of the Board of Directors on the same date.

Share Allotment Details

The company allotted 75 equity shares with a face value of ₹2.00 each to eligible employees upon exercise of stock options granted under the AACL-ESOP 2018 scheme. This allotment represents the execution of previously granted employee stock options under the company's established employee benefit program.

Impact on Share Capital

The allotment has resulted in a marginal increase in the company's paid-up equity share capital. The capital structure has been updated to reflect the new share issuance under the employee stock option plan.

Regulatory Compliance

The company has fulfilled its disclosure obligations under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification has been filed with both BSE (scrip code: 506767) and NSE (symbol: ALKYLAMINE) as required under SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

The original ESOP-2018 scheme filing dates were February 2, 2019 for BSE and February 4, 2019 for NSE. No lock-in period applies to these allotted shares, and they will rank pari passu with existing equity shares of the company.

Listing and Fee Structure

Since the company's paid-up capital remains within the ₹100 crores slab, no additional listing fees are payable for the newly issued equity shares. The company has already paid the requisite listing fees for this capital range, covering the current allotment under the existing fee structure.

The allotment demonstrates the company's commitment to its employee incentive programs while maintaining compliance with all regulatory requirements for listed entities.

Alkyl Amines Chemicals Limited , a leading manufacturer of aliphatic amines and amine derivatives, reported a subdued performance for the first half of fiscal year 2026, primarily due to geopolitical pressures and market challenges. The company's Executive Director, Kirat Patel, provided insights into the factors affecting their performance during a recent earnings conference call.

Key Highlights

• Flat topline performance despite marginal volume growth
• US government actions significantly impacted the company's operations
• Methylamines segment more affected than ethylamines
• Anti-dumping duties on acetonitrile expected to show benefits from Q4 onwards

Impact of US Government Actions

Alkyl Amines faced challenges on multiple fronts due to US government actions:

1. Direct US exports affected
2. Reduced customer demand due to their US export challenges
3. Increased Chinese competition in domestic markets
4. Sanctions on some Indian distributors in their supply chain

Segment Performance

The methylamines segment experienced a more significant impact compared to ethylamines. The overall market is facing a capacity overhang with the entry of Aarti Drugs as the fourth player in the industry.

Capacity Utilization and Future Projects

Mr. Patel mentioned that the company's ethylamine plant, commissioned about a year and a half ago with a capacity of 30,000 tons, is currently operating at 60-70% utilization. This provides room for growth as market conditions improve.

Alkyl Amines is also progressing on a new Rs. 120.00 crore project in Kurkumbh, targeting the dyes, pigments, and electronics markets. The mechanical completion of this project is expected by February-March 2026.

Acetonitrile Market

The implementation of anti-dumping duties on acetonitrile in June is anticipated to yield benefits from the fourth quarter onwards. However, Chinese competitors remain aggressive on pricing, presenting ongoing challenges in this segment.

Market Outlook

Management anticipates that the current subdued demand conditions may continue due to ongoing geopolitical uncertainties. However, they remain optimistic about long-term growth prospects as global trade situations stabilize.

Financial Performance

While specific financial figures were not disclosed, the company reported:

• Flat topline performance in H1 FY26
• Marginal volume growth
• Managed to retain profitability despite market pressures

Conclusion

Alkyl Amines Chemicals Limited faces a challenging business environment due to geopolitical pressures and market dynamics. However, the company's diversified product portfolio, ongoing expansion projects, and potential benefits from anti-dumping duties on acetonitrile provide some optimism for future growth. As global trade situations stabilize, the company expects to return to its normal growth trajectory.